bioMerieux (OTCMKTS:BMXMF) Stock Price Down 3.5% - What's Next?

bioMerieux (OTCMKTS:BMXMF - Get Free Report) dropped 3.5% during trading on Monday . The stock traded as low as $137.51 and last traded at $137.51. Approximately 4 shares changed hands during trading, an increase of 51% from the average daily volume of 3 shares. The stock had previously closed at $142.45.

Analyst Upgrades and Downgrades

Separately, Royal Bank Of Canada lowered bioMerieux from a "moderate buy" rating to a "hold" rating in a report on Wednesday, May 7th.

bioMerieux Stock Performance

The company has a current ratio of 2.20, a quick ratio of 1.29 and a debt-to-equity ratio of 0.08. The firm has a fifty day moving average price of $138.15 and a 200 day moving average price of $127.72.

bioMerieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.